EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSBMUG00000009227
Gene Symbol: DHCR24
3 Cross references
209 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSBMUG00000012171
Gene Symbol: HMGCR
3 Cross references
272 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSBMUG00000014912
Gene Symbol: PDPK1
3 Cross references
244 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSBMUG00000017895
Gene Symbol: HPD
3 Cross references
207 Possible Orthologues:

40s Ribosomal Protein S27-Like

Ensembl ID : ENSBMUG00000000361
Gene Symbol: LOC106700663
2 Cross references
81 Possible Orthologues:

40s Ribosomal Protein S29

Ensembl ID : ENSBMUG00000001865
Gene Symbol: LOC102282720
2 Cross references
57 Possible Orthologues:

40s Ribosomal Protein S30

Ensembl ID : ENSBMUG00000003833
Gene Symbol: LOC102272228
2 Cross references
225 Possible Orthologues:

40s Ribosomal Protein S4

Ensembl ID : ENSBMUG00000010234
Gene Symbol: LOC102277600
2 Cross references
160 Possible Orthologues:

40s Ribosomal Protein S4, X Isoform

Ensembl ID : ENSBMUG00000014754
Gene Symbol: LOC102275182
2 Cross references
168 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSBMUG00000011523
Gene Symbol: NT5E
3 Cross references
250 Possible Orthologues:

5-Hydroxytryptamine Receptor 1a

Ensembl ID : ENSBMUG00000004426
Gene Symbol: HTR1A
3 Cross references
150 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSBMUG00000000210
Gene Symbol: HTR1B
3 Cross references
244 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).